In 2024, the United States holds the largest R&D health share, albeit declining sharply by 14.95% in 2023. Japan and Russia display contrasting growths, with Japan increasing by 5.48% and Russia slightly up by 1.22%. European countries such as the Netherlands and Austria show significant gains of 77.69% and 79.47%, respectively; whereas, France and Australia face downturns of 1.2% and 15.43%. While smaller nations like Luxembourg and Slovenia experience growth, Slovakia and Hungary see substantial reductions.
Future trends to monitor include evolving allocations in emerging economies and fluctuating economic conditions impacting budget priorities. High growth in countries like Austria suggests a potential shift in global R&D health focus. Emerging technologies and health challenges may drive investment in broader geographies in the coming years.
Top countries in Government Budget Appropriations or Outlays for R&D in Health Share by Country (Million US Dollars PPP)
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 42.84 | 2023 | -3.34% | -14.95% | View data |
| 2 | 2 Japan | 31.93 | 2023 | +4.62% | +5.48% | View data |
| 3 | 3 Russia | 12.02 | 2023 | +1.24% | +1.22% | View data |
| 4 | 4 France | 11.57 | 2023 | +3.5% | -1.2% | View data |
| 5 | 5 Netherlands | 4.34 | 2023 | +5.71% | +77.69% | View data |
| 6 | 6 Austria | 2.54 | 2023 | +6.45% | +79.47% | View data |
| 7 | 7 Denmark | 2.36 | 2023 | +5.25% | +3.73% | View data |
| 8 | 8 Czech Republic | 1.8 | 2023 | +4.42% | +65.77% | View data |
| 9 | 9 Australia | 1.46 | 2023 | -0.75% | -15.43% | View data |
| 10 | 10 Portugal | 0.81 | 2023 | +4.07% | -0.16% | View data |
